Would you like to receive important updates about Abbott Laboratories like earnings dates and more?
The Year To Date (YTD) return is +0.88%.
The 52 Week Low stock price is 39.25 set on Wed, Jan 25, 2017 which is 360 days ago.
The current price per share is 51.11% above the 52 week low.
The 52 Week High stock price is $59.68 set on Fri, Jan 19, 2018 which is 1 days ago.
The current price per share is -0.62% below the 52 week high.
The All Time High stock price is $59.68 set on Fri, Jan 19, 2018 which is 1 days ago.
The current price per share is -0.62% below the all time high.
The Abbott Labs 5 year stock chart shows the historical prices over the previous 60 months.
The Abbott Labs 1 year stock chart shows the historical prices over the previous 12 months.
The 50 Day Moving Average is at $49.31 which is 20.28% below the stock price of $59.31.
The 200 Day Moving Average is at 44.57 which is 33.07% below the stock price of $59.31.
Because both the 50 DMA and 200 DMA are below the current stock price, this can be considered a bullish technical indicator.
Since the stock price is very far from both moving averages, a price retracement towards the moving averages should not be unexpected.
Abbott Laboratories is a Health Care stock that trades on the NYSE and has a market capitalization of $103.24 Billion.
ABT is also one of the largest companies by market capitalization today.
Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States. Its Diagnostic Products include a range of diagnostic systems and tests. Its Nutritional Products include a range of pediatric and adult nutritional products. Its Company's Vascular Products include a range of coronary, endovascular, vessel closure and structural heart devices for the treatment of vascular disease. The Company, through St. Jude Medical, Inc., also offers products, such as rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products and neuromodulation products.
Below are several other Medical Equipment & Devices stocks include Agilent Technologies Inc (A), Abbott Laboratories (ABT), Baxter International Inc (BAX), CR Bard Inc (BCR), Becton Dickinson and Co (BDX), Boston Scientific Corp (BSX), Danaher Corp (DHR), Edwards Lifesciences Corp (EW), Hologic, Inc (HOLX), IDEXX Laboratories, Inc (IDXX), .
The EPS is $1.21.
The P/E Ratio is 48.90%.
The Earnings Release Date was Wed, Oct 18, 2017.
Since this earnings release 94 days ago, the stock price is up by +7.72%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The next Earnings Release Date is, before the market open, on Wed, Jan 24, 2018, which is in 4 days.
The Annual Dividend Yield is 1.89%.
Abbott Laboratories is one of the few S&P 500 Dividend Aristocrats stocks.
The Dividend Aristocrats are S&P 500 constituents that have increased their dividend payouts for 25 consecutive years. The companies that make up the Dividend Aristocrats span ten different business sectors with both growth and value holdings. Wikipedia
Since the Ex-Date on Thu, Jan 11, 2018, 9 days ago, the stock price is up by 0.61%. (The next ex-dividend date will be around Wed, Apr 11, 2018.)
The Pay Date is Thu, Feb 15, 2018 which is in 26 days.
Investors should understand the dividend history of a company. Dividend history will show the dividend payments disbursed to investors over the years.